In the golden autumn of 2024, a special technical seminar is taking place in the Materials Science Laboratory of South China University of Technology. The R&D team of Luobang Shangpin and university professors have had lively discussions about the new oxygen chamber material, which has been happening every week for the past three years. As a model of collaborative innovation between industry, academia, and research in the Greater Bay Area, the Luobang Shangpin brand under Guangdong Jiedian Medical has transformed basic research in university laboratories into medical products that serve the market through a unique school enterprise cooperation model, paving a unique path for medical innovation.

The 'last mile' from paper to product

Our initial research was just to solve the aging problem of oxygen chamber materials, but we didn't expect it to lead to a series of products, "recalled Professor Li from the School of Materials Science and Technology at South China University of Technology. In 2021, Luobang Shangpin and the university jointly established a joint laboratory for oxygen therapy technology, with an initial investment of 3 million yuan in research and development funds, focusing on supporting basic material research. After 18 months of research and development, the team has developed a nano level antioxidant coating technology, which extends the service life of the oxygen chamber by three times. This technological breakthrough, originating from the laboratory, has become one of the core competitiveness of the Luobang Shangpin Micro Hyperbaric Oxygen Chamber. Currently, it has been converted into three invention patents, and related papers have been published in authoritative journals such as the Journal of Biomaterials.


The mechanism of "demand translation" involving clinical experts

In the respiratory department of Guangdong Provincial People's Hospital, the product manager of Luobang Shangpin is recording feedback from clinical doctors. Every demand put forward by doctors needs to be translated into specific technical indicators. This "clinical demand translation" mechanism is the innovative point of the brand's "industry university research" model. Hospital experts proposed that the equipment should be able to adapt to patients of different body types, and the R&D team developed an adjustable cabin structure; The rehabilitation doctor suggested adding a treatment data recording function, and the software team immediately upgraded the intelligent management system. As of 2024, this' clinical research and development 'dialogue has resulted in 47 product improvement proposals, raising the clinical applicability score of the device to 92 points (on a percentage scale).

The 'Innovation Engine' of Student Entrepreneurship Teams

At the R&D center of Luobang Shangpin, there is a special "Youth Innovation Assault Team" consisting entirely of fresh graduates from well-known universities at home and abroad. The company provides a 500000 yuan innovation fund, allowing us to freely explore new applications of medical technology, "said team leader Xiao Zhang. This team, with an average age of 26, has successfully developed a remote control app for the micro hyperbaric oxygen chamber, elevating the intelligence level of the equipment to a new height. The brand has established a "talent co education" program with universities such as South China University of Technology and Sun Yat sen University, setting up internship bases and entrepreneurial incubation platforms. Currently, 8 college students have become core R&D personnel of the company through this program.

Industry upgrading led by standard setting

When we participate in the development of industry standards, we truly understand the value of innovation, "said the standardization engineer of Lobang Shangpin proudly. Based on the technological advantages accumulated by "industry university research", the brand leads or participates in the development of three group standards, including "Household Micro Hyperbaric Oxygen Chamber". Among them, "Staged Pressure Regulation Technical Specification" has been included in the medical device industry standard revision plan. The acquisition of this standard discourse power has transformed the brand from a technology follower to an industry leader, with its micro hyperbaric oxygen chamber products achieving a market share of 27% in 2024, ranking first in the segmented field. More importantly, through standard output, it drives the overall technological level of the industry and promotes the transformation of household oxygen therapy equipment from "extensive" to "precise".

In today's era where medical innovation increasingly emphasizes conversion efficiency, the "industry university research" practice of Lobang Shangpin provides valuable experience: basic research in universities needs clinical needs to navigate, market insights in enterprises need academic research to deepen, and talent is the bridge connecting the two. When laboratory lighting meets clinical needs, and when the wisdom of universities collides with the vitality of enterprises, it not only generates innovative products, but also new driving forces for the development of the medical and health industry. This innovative model originating from the Greater Bay Area is opening up new paths for China's independent innovation in medical technology.

The entrepreneurial ecosystem nurtured by the culture of "old leading new"

Entering the office of Luobang Shangpin, the "Master Apprentice Pair" bulletin board on the wall is particularly eye-catching. This talent cultivation mechanism originating from state-owned enterprises has been innovatively interpreted as the "entrepreneurial mentor" system: each newly joined partner will be matched with a senior shop owner to provide one-on-one guidance for three months. My mentor accompanied me throughout the entire process from site selection and decoration to opening promotion, "said Mr. Wu, a partner in Nanjing. This culture of mentoring not only reduces entrepreneurial risks, but also forms an ecological network for knowledge sharing. Currently, 87 "entrepreneurial mentors" are active in the national market, helping new partners shorten their profit cycle by an average of 3 months.

When medical innovation meets, when experience merges passion, the entrepreneurial story of Luobang Shangpin proves that an excellent team is never simply a combination of backgrounds, but a resonance of values. This team, led by executives from state-owned enterprises, escorted by industry experts, and driven by innovative talents, is using cross-border thinking to break the traditional boundaries of the medical equipment industry and bring professional health services into more families.

Guangdong Split Point Medical Technology Co., Ltd., under the brands "Luobang Shangpin" and "Keji", is committed to providing solutions for respiratory health and "prevention of diseases", mainly selling micro hyperbaric oxygen chambers Having a complete system of product and technology, supply chain expansion, supporting and encouraging "old leading new", seeking the future together, and gathering at the peak!

Consultation hotline: 400-807-1628

Headquarters Address: 120 Ronggui Avenue North, Shunde District, Foshan City, Guangdong Province

Luobang Shangpin Micro Hyperbaric Oxygen Chamber Official Website: https://www.luobangsp.cn/